{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T01:30:59Z","timestamp":1793669459520,"version":"4.5.1"},"reference-count":45,"publisher":"American Society of Hematology","issue":"19","license":[{"start":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T00:00:00Z","timestamp":1720742400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10,8]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>Inflammation promotes solid tumor progression, but how regulatory mechanisms of inflammation may affect leukemia is less well studied. Using annexin A5 (ANXA5), a calcium-binding protein known for apoptosis, which we discovered to be differentially expressed in the bone marrow microenvironment (BMM) of mice with acute myeloid (AML) vs chronic myeloid leukemia, as a model system, we unravel here a circuit in which AML\u2013derived tumor necrosis factor \u03b1 (TNF-\u03b1) dose-dependently reduces ANXA5 in the BMM. This creates an inflammatory BMM via elevated levels of prostaglandin E2 (PGE2). Via binding to its EP4 receptor, PGE2 increases \u03b2-catenin and hypoxia-inducible factor 1\u03b1 signaling in AML cells, thereby accelerating PGE2-sensitive AML. Human trephine biopsies may show lower ANXA5 expression and higher PGE2 expression in AML than other hematologic malignancies. Furthermore, syngeneic and xenogeneic transplantation models suggest a survival benefit after treatment with the inhibitor of prostaglandin-endoperoxide synthase 2 (cyclooxygenase 2 [COX2]), celecoxib, plus cytarabine in those AML types highly sensitive to PGE2 compared with cytarabine alone. Taken together, TNF-\u03b1\/ANXA5\/NF-\u03baB\/COX2\/PGE2\u2013mediated inflammation influences AML course in a highly differential and circular manner, and patients with AML with \u201cinflammatory AML\u201d may benefit from antiphlogistic agents as adjunct therapy.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/bloodadvances.2024012867","type":"journal-article","created":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T19:58:26Z","timestamp":1720814306000},"page":"4983-4996","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":16,"title":["Differential inflammatory conditioning of the bone marrow by acute myeloid leukemia and its impact on progression"],"prefix":"10.1182","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9296-9403","authenticated-orcid":false,"given":"Valentina R.","family":"Minciacchi","sequence":"first","affiliation":[{"name":"1Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt am Main, Germany"},{"name":"2Center for Thrombosis and Hemostasis, Johannes Gutenberg University Medical Center, Mainz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Karantanou","sequence":"additional","affiliation":[{"name":"1Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt am Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimena","family":"Bravo","sequence":"additional","affiliation":[{"name":"1Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt am Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel S.","family":"Pereira","sequence":"additional","affiliation":[{"name":"1Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt am Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costanza","family":"Zanetti","sequence":"additional","affiliation":[{"name":"1Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt am Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Krack","sequence":"additional","affiliation":[{"name":"1Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt am Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Kumar","sequence":"additional","affiliation":[{"name":"1Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt am Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4033-4966","authenticated-orcid":false,"given":"Katrin","family":"Bankov","sequence":"additional","affiliation":[{"name":"3Department of Pathology, Goethe University, Frankfurt am Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3424-1091","authenticated-orcid":false,"given":"Sylvia","family":"Hartmann","sequence":"additional","affiliation":[{"name":"3Department of Pathology, Goethe University, Frankfurt am Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0312-161X","authenticated-orcid":false,"given":"Brian J. P.","family":"Huntly","sequence":"additional","affiliation":[{"name":"4Department of Haematology, University of Cambridge, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eshwar","family":"Meduri","sequence":"additional","affiliation":[{"name":"4Department of Haematology, University of Cambridge, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6064-2166","authenticated-orcid":false,"given":"Wolfram","family":"Ruf","sequence":"additional","affiliation":[{"name":"2Center for Thrombosis and Hemostasis, Johannes Gutenberg University Medical Center, Mainz, Germany"},{"name":"5Department of Immunology and Microbiology, Scripps Research, La Jolla, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3603-1119","authenticated-orcid":false,"given":"Daniela S.","family":"Krause","sequence":"additional","affiliation":[{"name":"6German Cancer Research Center (DKFZ), Heidelberg, Germany"},{"name":"7German Cancer Consortium (DKTK), Heidelberg, Germany"},{"name":"8Institute of Transfusion Medicine - Transfusion Centre, Johannes Gutenberg University Medical Centre, Mainz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2024,9,25]]},"reference":[{"issue":"1","key":"2024100812553253800_bib1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","article-title":"Inflammation and cancer: triggers, mechanisms, and consequences","volume":"51","author":"Greten","year":"2019","journal-title":"Immunity"},{"issue":"6","key":"2024100812553253800_bib2","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"issue":"5","key":"2024100812553253800_bib3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41571-020-00459-9","article-title":"Targeting cancer-promoting inflammation - have anti-inflammatory therapies come of age?","volume":"18","author":"Hou","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"2024100812553253800_bib4","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1182\/hematology.2019000045","article-title":"Inflammatory bone marrow microenvironment","volume":"2019","author":"Leimk\u00fchler","year":"2019","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"2024100812553253800_bib5","doi-asserted-by":"crossref","first-page":"100711","DOI":"10.1016\/j.blre.2020.100711","article-title":"Role of inflammation in the biology of myeloproliferative neoplasms","volume":"42","author":"Koschmieder","year":"2020","journal-title":"Blood Rev"},{"issue":"5","key":"2024100812553253800_bib6","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41568-020-0245-2","article-title":"Bone marrow niches in haematological malignancies","volume":"20","author":"M\u00e9ndez-Ferrer","year":"2020","journal-title":"Nat Rev Cancer"},{"issue":"20","key":"2024100812553253800_bib7","first-page":"4665","article-title":"Hodgkin lymphoma: a special microenvironment","volume":"10","author":"Opinto","year":"2021","journal-title":"J\u00a0Clin Med"},{"issue":"1","key":"2024100812553253800_bib8","first-page":"27","article-title":"An inflammatory state remodels the immune microenvironment and improves risk stratification in acute myeloid leukemia","volume":"4","author":"Lasry","year":"2023","journal-title":"Nat Cancer"},{"issue":"6","key":"2024100812553253800_bib9","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1021\/ac801267s","article-title":"Detection of apoptosis based on the interaction between annexin V and phosphatidylserine","volume":"81","author":"Liu","year":"2009","journal-title":"Anal Chem"},{"issue":"6","key":"2024100812553253800_bib10","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1111\/j.1538-7836.2012.04716.x","article-title":"Diannexin, an annexin A5 homodimer, binds phosphatidylserine with high affinity and is a potent inhibitor of platelet-mediated events during thrombus formation","volume":"10","author":"Rand","year":"2012","journal-title":"J\u00a0Thromb Haemost"},{"issue":"43","key":"2024100812553253800_bib11","doi-asserted-by":"crossref","first-page":"74263","DOI":"10.18632\/oncotarget.19392","article-title":"Annexin A5 suppresses cyclooxygenase-2 expression by downregulating the protein kinase C-\u03b6-nuclear factor-\u03baB signaling pathway in prostate cancer cells","volume":"8","author":"Baek","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"2024100812553253800_bib12","doi-asserted-by":"crossref","first-page":"6753","DOI":"10.1038\/s41598-018-25143-y","article-title":"Annexin A5 reduces infarct size and improves cardiac function after myocardial ischemia-reperfusion injury by suppression of the cardiac inflammatory response","volume":"8","author":"de Jong","year":"2018","journal-title":"Sci Rep"},{"issue":"13","key":"2024100812553253800_bib13","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1016\/j.celrep.2017.03.018","article-title":"Identification of interleukin-1 by functional screening as a key mediator of cellular expansion and disease progression in acute myeloid leukemia","volume":"18","author":"Carey","year":"2017","journal-title":"Cell Rep"},{"issue":"6","key":"2024100812553253800_bib14","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1158\/0008-5472.CAN-18-0921","article-title":"An ARC-regulated IL1\u03b2\/Cox-2\/PGE2\/\u03b2-catenin\/ARC circuit controls leukemia-microenvironment interactions and confers drug resistance in AML","volume":"79","author":"Carter","year":"2019","journal-title":"Cancer Res"},{"issue":"11","key":"2024100812553253800_bib15","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/nm.3364","article-title":"Differential regulation of myeloid leukemias by the bone marrow microenvironment","volume":"19","author":"Krause","year":"2013","journal-title":"Nat Med"},{"issue":"1","key":"2024100812553253800_bib16","doi-asserted-by":"crossref","first-page":"6242","DOI":"10.1038\/s41467-023-41770-0","article-title":"Distinct and targetable role of calcium-sensing receptor in leukaemia","volume":"14","author":"Pereira","year":"2023","journal-title":"Nat Commun"},{"issue":"2","key":"2024100812553253800_bib17","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0925-4773(01)00532-9","article-title":"Sequential expression of annexin A5 in the vasculature and skeletal elements during mouse development","volume":"109","author":"Brachvogel","year":"2001","journal-title":"Mech Dev"},{"issue":"1","key":"2024100812553253800_bib18","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1074\/jbc.M117.809681","article-title":"Cell-surface phosphatidylserine regulates osteoclast precursor fusion","volume":"293","author":"Verma","year":"2018","journal-title":"J\u00a0Biol Chem"},{"issue":"1","key":"2024100812553253800_bib19","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1083\/jcb.201207012","article-title":"Extracellular annexins and dynamin are important for sequential steps in myoblast fusion","volume":"200","author":"Leikina","year":"2013","journal-title":"J\u00a0Cell Biol"},{"key":"2024100812553253800_bib20","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/srep00827","article-title":"Loss of maternal annexin A5 increases the likelihood of placental platelet thrombosis and foetal loss","volume":"2","author":"Ueki","year":"2012","journal-title":"Sci Rep"},{"issue":"7755","key":"2024100812553253800_bib21","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41586-019-1104-8","article-title":"The bone marrow microenvironment at single-cell resolution","volume":"569","author":"Tikhonova","year":"2019","journal-title":"Nature"},{"issue":"32","key":"2024100812553253800_bib22","doi-asserted-by":"crossref","first-page":"23218","DOI":"10.1074\/jbc.M602075200","article-title":"Protein kinase C delta (deltaPKC)-annexin V interaction: a required step in deltaPKC translocation and function","volume":"281","author":"Kheifets","year":"2006","journal-title":"J\u00a0Biol Chem"},{"issue":"41","key":"2024100812553253800_bib23","doi-asserted-by":"crossref","first-page":"14214","DOI":"10.1074\/jbc.RA120.015143","article-title":"Annexin A5 is essential for PKC\u03b8 translocation during T-cell activation","volume":"295","author":"Hu","year":"2020","journal-title":"J\u00a0Biol Chem"},{"issue":"15","key":"2024100812553253800_bib24","doi-asserted-by":"crossref","first-page":"20054","DOI":"10.18632\/oncotarget.7911","article-title":"Anti-apoptotic ARC protein confers chemoresistance by controlling leukemia-microenvironment interactions through a NFkappaB\/IL1beta signaling network","volume":"7","author":"Carter","year":"2016","journal-title":"Oncotarget"},{"issue":"6","key":"2024100812553253800_bib25","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/s41375-019-0674-7","article-title":"Bone marrow niche-derived extracellular matrix-degrading enzymes influence the progression of B-cell acute lymphoblastic leukemia","volume":"34","author":"Verma","year":"2020","journal-title":"Leukemia"},{"issue":"8","key":"2024100812553253800_bib27","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1038\/s41375-020-0866-1","article-title":"Specific, targetable interactions with the microenvironment influence imatinib-resistant chronic myeloid leukemia","volume":"34","author":"Kumar","year":"2020","journal-title":"Leukemia"},{"issue":"5973","key":"2024100812553253800_bib28","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1126\/science.1186624","article-title":"The Wnt\/beta-catenin pathway is required for the development of leukemia stem cells in AML","volume":"327","author":"Wang","year":"2010","journal-title":"Science"},{"issue":"4","key":"2024100812553253800_bib29","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.stem.2011.02.006","article-title":"Targeting HIF1alpha eliminates cancer stem cells in hematological malignancies","volume":"8","author":"Wang","year":"2011","journal-title":"Cell Stem Cell"},{"issue":"7728","key":"2024100812553253800_bib26","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41586-018-0623-z","article-title":"Functional genomic landscape of acute myeloid leukaemia","volume":"562","author":"Tyner","year":"2018","journal-title":"Nature"},{"issue":"7147","key":"2024100812553253800_bib30","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/nature05883","article-title":"Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis","volume":"447","author":"North","year":"2007","journal-title":"Nature"},{"issue":"11","key":"2024100812553253800_bib45","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1182\/blood.V112.11.753.753","article-title":"The clinical utility of microarray-based gene expression profiling in the diagnosis and sub-classification of leukemia: final report on 3252 cases from the international mile study group","volume":"112","author":"Haferlach","year":"2008","journal-title":"Blood"},{"issue":"3","key":"2024100812553253800_bib31","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.stem.2013.06.009","article-title":"Myeloproliferative neoplasia remodels the endosteal bone marrow niche into a self-reinforcing leukemic niche","volume":"13","author":"Schepers","year":"2013","journal-title":"Cell Stem Cell"},{"issue":"10","key":"2024100812553253800_bib32","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1016\/j.celrep.2016.11.019","article-title":"Inflammation-induced oxidative stress mediates gene fusion formation in prostate cancer","volume":"17","author":"Mani","year":"2016","journal-title":"Cell Rep"},{"issue":"5","key":"2024100812553253800_bib33","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.stem.2016.08.021","article-title":"Mesenchymal inflammation drives genotoxic stress in hematopoietic stem cells and predicts disease evolution in human pre-leukemia","volume":"19","author":"Zambetti","year":"2016","journal-title":"Cell Stem Cell"},{"issue":"5","key":"2024100812553253800_bib34","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1182\/blood.V92.5.1652","article-title":"Antiphospholipid antibodies accelerate plasma coagulation by inhibiting annexin-V binding to phospholipids: a \"lupus procoagulant\" phenomenon","volume":"92","author":"Rand","year":"1998","journal-title":"Blood"},{"issue":"11","key":"2024100812553253800_bib35","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1182\/blood-2009-04-213520","article-title":"Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug","volume":"115","author":"Rand","year":"2010","journal-title":"Blood"},{"issue":"11","key":"2024100812553253800_bib36","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1038\/leu.2013.135","article-title":"The MLL recombinome of acute leukemias in 2013","volume":"27","author":"Meyer","year":"2013","journal-title":"Leukemia"},{"issue":"1","key":"2024100812553253800_bib37","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ccr.2011.06.020","article-title":"Cell of origin in AML: susceptibility to MN1-induced transformation is regulated by the MEIS1\/AbdB-like HOX protein complex","volume":"20","author":"Heuser","year":"2011","journal-title":"Cancer Cell"},{"issue":"5","key":"2024100812553253800_bib38","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.3324\/haematol.2018.211201","article-title":"Meningioma 1 is indispensable for mixed lineage leukemia-rearranged acute myeloid leukemia","volume":"105","author":"Sharma","year":"2020","journal-title":"Haematologica"},{"issue":"6","key":"2024100812553253800_bib39","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.cell.2019.01.031","article-title":"Single-cell RNA-seq reveals AML hierarchies relevant to disease progression and immunity","volume":"176","author":"van Galen","year":"2019","journal-title":"Cell"},{"issue":"6","key":"2024100812553253800_bib40","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/s41591-022-01819-x","article-title":"A\u00a0cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia","volume":"28","author":"Zeng","year":"2022","journal-title":"Nat Med"},{"issue":"9","key":"2024100812553253800_bib41","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1158\/2159-8290.CD-22-1297","article-title":"A\u00a0novel type of monocytic leukemia stem cell revealed by the clinical use of venetoclax-based therapy","volume":"13","author":"Pei","year":"2023","journal-title":"Cancer Discov"},{"issue":"650","key":"2024100812553253800_bib42","doi-asserted-by":"crossref","first-page":"eabn3248","DOI":"10.1126\/scitranslmed.abn3248","article-title":"CKS1 inhibition depletes leukemic stem cells and protects healthy hematopoietic stem cells in acute myeloid leukemia","volume":"14","author":"Grey","year":"2022","journal-title":"Sci Transl Med"},{"issue":"1","key":"2024100812553253800_bib43","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/35094017","article-title":"Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2","volume":"1","author":"Gupta","year":"2001","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"2024100812553253800_bib44","doi-asserted-by":"crossref","first-page":"e0245581","DOI":"10.1371\/journal.pone.0245581","article-title":"Prognostic significance of BIRC7\/Livin, Bcl-2, p53, Annexin V, PD-L1, DARC, MSH2 and PMS2 in colorectal cancer treated with FOLFOX chemotherapy with or without aspirin","volume":"16","author":"Faruk","year":"2021","journal-title":"PLoS One"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/19\/4983\/2245583\/blooda_adv-2024-012867-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/19\/4983\/2245583\/blooda_adv-2024-012867-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T16:11:38Z","timestamp":1728403898000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/8\/19\/4983\/517005\/Differential-inflammatory-conditioning-of-the-bone"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,25]]},"references-count":45,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2024,10,8]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2024012867","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,25]]}}}